Have a personal or library account? Click to login
Influence of Risk Factors and Diabetic Complications on Peripheral Nerve Function in Type 2 Diabetes Mellitus Cover

Influence of Risk Factors and Diabetic Complications on Peripheral Nerve Function in Type 2 Diabetes Mellitus

Acta Marisiensis - Seria Medica
Volume 61 (2015): Issue 1 (March 2015)
By: Bălașa Rodica,  Z. Bajko,  Smaranda Maier,  S. Voidăzan and  Anca Moțățăianu  
Open Access
|Jun 2015

References

  1. 1. Boulton AJ, Vinik AI, Arezzo JC et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28:956-962.10.2337/diacare.28.4.95615793206
    Search in Google Scholar
  2. 2. Llewelyn JG, Tomlinson DR, Thomas PK. Diabetic Neuropathies. In: Dck PJ, Thomas PK [Eds]. Peripheral Neuropathy, Fourth Edition, Elsevier Saunders, Philadelphia 2005: 1951-1991.10.1016/B978-0-7216-9491-7.50088-0
    Search in Google Scholar
  3. 3. Vinik AI, Maser RE, Mitchell BD et al. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579.10.2337/diacare.26.5.155312716821
    Search in Google Scholar
  4. 4. Gibbons CH, Freeman R, Veves A. Diabetic neuropathy: a cross-sectional study of the relationship among test of neurophysiology. Diabetes Care 2010; 33: 2629-2634.10.2337/dc10-0763299220320805259
    Search in Google Scholar
  5. 5. Stratton IM, Adler AI, Neil HA et al on behalf of the UKPDS Group. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000; 32: 405-12.10.1136/bmj.321.7258.4052745410938048
    Search in Google Scholar
  6. 6. American Diabetes Association, American Academy of Neurology. Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. Diabetes Care 1988; 11: 592-597.10.2337/diacare.11.7.5923060328
    Search in Google Scholar
  7. 7. Kimura J. Principles and variations of nerve conduction studies. In: Kimura J [Ed]. Electrodiagnosis in Diseases of the Nerve and Muscle: Principles and practice, Oxford University Press, New York 2013: 91-129.10.1093/med/9780199738687.001.0001
    Search in Google Scholar
  8. 8. Ewing DJ, Martyn CN, Young RJ et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985; 8: 491-498.10.2337/diacare.8.5.4914053936
    Search in Google Scholar
  9. 9. Spallone V, Ziegler D, Freeman R et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis and management. Diabetes Metab Res Rev 2011; 27: 639-653.10.1002/dmrr.123921695768
    Search in Google Scholar
  10. 10. Ziegler D, Laux G, Dannehl K et al. Assessment of cardiovascular autonomic function: age- related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses. Diabet Med 1992; 9: 166-175.10.1111/j.1464-5491.1992.tb01754.x1563252
    Search in Google Scholar
  11. 11. Tesfaye S, Boulton AJ, Dyck PJ et al. Diabetic Neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-2293.10.2337/dc10-1303
    Search in Google Scholar
  12. 12. Wendelhag I, Gustavsson T, Suurkula M et al. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of computerized image analyzing system. Clin Physiol 1991; 11: 565-577.10.1111/j.1475-097X.1991.tb00676.x
    Search in Google Scholar
  13. 13. Dyck PJ, Carter RE, Litchy WJ. Modeling nerve conduction criteria for diagnosis of diabetic polyneuropathy. Muscle Nerve 2011; 44: 340-345.10.1002/mus.22074
    Search in Google Scholar
  14. 14. Karsidag S, Morali S, Sargin M et al. The electrophysiological findings of subclinical neuropathy in patients with recently diagnosed type 1 diabetes mellitus. Diabetes Res Clin Pract 2005; 67: 211-219.10.1016/j.diabres.2004.07.017
    Search in Google Scholar
  15. 15. Said G. Diabetic neuropathy: an update. J. Neurol 1996; 243: 431-440.
    Search in Google Scholar
  16. 16. Thomas PK. Diabetic neuropathy: mechanism and future treatment options. J Neurol Neurosurg Psychiatry 1999; 67: 277-9.10.1136/jnnp.67.3.277
    Search in Google Scholar
  17. 17. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabet Metab 1977; 3: 173-182.
    Search in Google Scholar
  18. 18. Tesfaye S, Stevens LK, Stephenson JM et al. Prevalence of diabetic peripheral neuropathy and its relation with glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia 1996; 39: 1377-1384.10.1007/s001250050586
    Search in Google Scholar
  19. 19. Valensi P, Giroux C, Seeboth-Ghalayini B et al. Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control and vascular factors. J Diabetes Complications 1997; 11: 27-34.10.1016/S1056-8727(95)00086-0
    Search in Google Scholar
  20. 20. Tkac I, Bril V. Glycemic control is related to the electrophysiological severity of diabetic peripheral sensorimotor polyneuropathy. Diabetes Care 1998; 21: 1749-1752.10.2337/diacare.21.10.1749
    Search in Google Scholar
  21. 21. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.10.1016/S0140-6736(98)07019-6
    Search in Google Scholar
  22. 22. Partanen J, Niskanen L, Lehtinen J et al. Natural history of peripheral neuropathy in patients with non-insulin dependent diabetes. N Engl J Med 1995; 333: 89-94.10.1056/NEJM1995071333302037777034
    Search in Google Scholar
  23. 23. Dyck PJ, Davies JL, Wilson DM et al. Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 1999; 22: 1479-1486.10.2337/diacare.22.9.147910480512
    Search in Google Scholar
  24. 24. Lehtinen JM, Niskanen L, Hyvonen K et al. Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulindependent) diabetes mellitus and in control subjects - 5-year follow-up. Diabetologia 1993; 36: 68-72.10.1007/BF003990968436256
    Search in Google Scholar
  25. 25. Brownlee M. Diabetic complications: pathobiology of hyperglycemic damage and potential impact on treatment. In: Thornalley PJ, Kempler P [Eds]. Complications of diabetes mellitus: pathophysiology and pathogenetically-based treatment options, Georg Thieme Verlag KG Stuttgart 2009: 1-8.
    Search in Google Scholar
  26. 26. Hammes HP. Diabetic nerve, vascular and organ damage from the pathogenetic key to new therapeutic approaches. In: Rett K [Ed]. Better chances for nerves and vessels, Georg Thieme Verlag KG Stuttgart 2011: 9-19.
    Search in Google Scholar
  27. 27. Toyry JP, Partanen JV, Niskanen LK et al. Divergent development of autonomic and peripheral somatic neuropathies in NIDDM. Diabetologia 1997; 40: 953-958.10.1007/s0012500507739267991
    Search in Google Scholar
  28. 28. Pop-Busui R, Evans GW, Gerstein HC , Fonseca V, Fleg JL, Hoogwerf et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial. Diabetes Care 2010; 33:1578-1584.10.2337/dc10-0125289036220215456
    Search in Google Scholar
  29. 29. Calles-Escandon J, Lovato LC, Simons-Morton DG, Kendall D, Pop-Busui R, Cohen R et al. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 2010; 33: 721-727.10.2337/dc09-1471284501220103550
    Search in Google Scholar
  30. 30. Papanas N, Symeonidis G, Mavridis G et al. Ankle-Brachial index: a surrogate marker of microvascular complications in type 2 diabetes mellitus? Int Angiol 2007; 26: 253-257.
    Search in Google Scholar
  31. 31. Brooks B, Dean R, Patel S, Wu B, Molyneaux L, Yue DK. TBI or not TBI: that is the question. Is better to measure toe pressure than ankle pressure in diabetic patients? Diabet Med 2001; 18: 528-532.
    Search in Google Scholar
  32. 32. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical Cardiovascular events wit Carotid Intima -Media Thickness. A systematic Review and Meta-Analysis. Circulation 2007; 115: 459-467. 10.1161/CIRCULATIONAHA.106.62887517242284
    Search in Google Scholar
DOI: https://doi.org/10.1515/amma-2015-0015 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 40 - 46
Submitted on: Jan 5, 2015
Accepted on: Jan 14, 2015
Published on: Jun 16, 2015
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
electrophysiological parameters,
motor and sensory nerve function,
cardiac autonomic neuropathy,
glycaemic control,
diabetes duration,
macroangiopathy
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2015 Bălașa Rodica, Z. Bajko, Smaranda Maier, S. Voidăzan, Anca Moțățăianu, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 61 (2015): Issue 1 (March 2015)Next article